These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32510470)

  • 1. Is innate immunity our best weapon for flattening the curve?
    Angka L; Market M; Ardolino M; Auer RC
    J Clin Invest; 2020 Aug; 130(8):3954-3956. PubMed ID: 32510470
    [No Abstract]   [Full Text] [Related]  

  • 2. A universal coronavirus vaccine.
    Koff WC; Berkley SF
    Science; 2021 Feb; 371(6531):759. PubMed ID: 33602830
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
    Poulas K; Farsalinos K; Zanidis C
    Front Immunol; 2020; 11():1373. PubMed ID: 32612613
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
    Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What about the original antigenic sin of the humans versus SARS-CoV-2?
    Roncati L; Palmieri B
    Med Hypotheses; 2020 Sep; 142():109824. PubMed ID: 32408068
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].
    García-Salido A
    An Pediatr (Engl Ed); 2020 Jul; 93(1):60.e1-60.e7. PubMed ID: 32439309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus reinfections: three questions scientists are asking.
    Ledford H
    Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
    [No Abstract]   [Full Text] [Related]  

  • 9. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
    Goudsmit J
    Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
    [No Abstract]   [Full Text] [Related]  

  • 10. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 11. The false promise of herd immunity for COVID-19.
    Aschwanden C
    Nature; 2020 Nov; 587(7832):26-28. PubMed ID: 33087872
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
    Vojdani A; Kharrazian D
    Clin Immunol; 2020 Aug; 217():108480. PubMed ID: 32461193
    [No Abstract]   [Full Text] [Related]  

  • 14. Do pets protect their owners in the COVID-19 era?
    Jurgiel J; Filipiak KJ; Szarpak Ł; Jaguszewski M; Smereka J; Dzieciątkowski T
    Med Hypotheses; 2020 Sep; 142():109831. PubMed ID: 32428810
    [No Abstract]   [Full Text] [Related]  

  • 15. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    Vignesh R; Shankar EM; Velu V; Thyagarajan SP
    Front Immunol; 2020; 11():586781. PubMed ID: 33101320
    [No Abstract]   [Full Text] [Related]  

  • 16. Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.
    Abid MA; Nunley L; Abid MB
    Front Immunol; 2020; 11():1294. PubMed ID: 32582221
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches and Challenges in SARS-CoV-2 Vaccine Development.
    Dagotto G; Yu J; Barouch DH
    Cell Host Microbe; 2020 Sep; 28(3):364-370. PubMed ID: 32798444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timely development of vaccines against SARS-CoV-2.
    Lu S
    Emerg Microbes Infect; 2020; 9(1):542-544. PubMed ID: 32148172
    [No Abstract]   [Full Text] [Related]  

  • 19. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 20. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.